BPC-157 Dosage Protocol Guide: Evidence-Based Dosing, Timing & Cycle Planning (2026)
Not medical advice — educational only. This content has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any peptide protocol.
Getting the BPC-157 dosage protocol right is the single most important factor in determining whether your cycle delivers meaningful results or falls flat. Too low and you waste time and money. Too high and you risk diminishing returns without additional benefit. The precision window matters — and this guide exists to help you find it based on the best available evidence.
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. Its primary mechanisms include VEGF-mediated angiogenesis (new blood vessel formation), nitric oxide modulation, and growth factor upregulation. These mechanisms make dosing strategy critical — the biological pathways BPC-157 activates are dose-dependent, meaning the amount you administer directly influences the magnitude and speed of response.
This guide covers every aspect of BPC-157 dosing: evidence-tiered ranges, weight-based calculations, timing optimization, cycle architecture, reconstitution math, and protocol design for different goals.
Understanding BPC-157 Dosage Ranges
Clinical evidence, expert practitioner protocols, and experimental community data all point to overlapping but distinct dosage ranges. Understanding these tiers helps you select a starting dose that matches both your experience level and your goals.
Evidence-Tiered Dosage Ranges
| Evidence Tier | Dose Range (per injection) | Daily Total | Best For |
|---|---|---|---|
| Clinical (animal-model extrapolated) | 200-500 mcg | 200-1000 mcg | Conservative, evidence-first approach |
| Expert (practitioner-recommended) | 250-500 mcg | 500-1000 mcg | Standard healing protocols |
| Experimental (advanced community) | 500-750 mcg | 750-1500 mcg | Severe injuries, accelerated timelines |
Weight-Based Dosing
Some leading practitioners recommend weight-based protocols for more individualized dosing:
| Body Weight | Conservative Dose | Standard Dose | Aggressive Dose |
|---|---|---|---|
| 120-150 lbs (55-68 kg) | 200 mcg 2x/day | 250 mcg 2x/day | 500 mcg 2x/day |
| 150-200 lbs (68-91 kg) | 250 mcg 2x/day | 350 mcg 2x/day | 500 mcg 2x/day |
| 200-250 lbs (91-113 kg) | 300 mcg 2x/day | 500 mcg 2x/day | 750 mcg 2x/day |
| 250+ lbs (113+ kg) | 350 mcg 2x/day | 500 mcg 2x/day | 750 mcg 2x/day |
Use the DoseCraft Calculator to convert your target dose into exact syringe units based on your reconstitution volume.
Optimal Dosing Frequency and Timing
BPC-157 has a relatively short half-life estimated at 2-4 hours in systemic circulation. This pharmacokinetic profile drives the dosing frequency recommendations used by clinical experts.
Frequency Options
| Frequency | Protocol | Rationale |
|---|---|---|
| 2x daily (recommended) | Morning + evening, 10-12 hours apart | Maintains more consistent tissue levels |
| 1x daily | Single morning or evening dose | Adequate for mild protocols; lower total exposure |
| 3x daily | Morning + afternoon + evening | Advanced/aggressive; rarely necessary |
Timing Optimization
- Morning dose: Administer on an empty stomach or 30 minutes before food. Growth factor signaling may be enhanced in fasted states.
- Evening dose: Administer 2-3 hours after last meal, before bed. Repair processes are upregulated during sleep.
- Near injury: If targeting a specific injury, inject subcutaneously as close to the site as anatomically practical. BPC-157 demonstrates stronger local effects near the administration site.
Consistency Is Non-Negotiable
Clinical experts consistently emphasize that maintaining a regular schedule matters more than the exact time of day. A 250 mcg dose administered reliably at the same two times every day will likely outperform a 500 mcg dose taken erratically. The DoseCraft Protocol Builder sets automated reminders to enforce consistency.
Cycle Architecture: Loading, Maintenance, and Rest
BPC-157 protocols are structured in cycles — defined periods of active use followed by time off. This architecture prevents receptor desensitization and allows the body to consolidate healing gains.
Standard Cycle Framework
| Phase | Duration | Dose | Purpose |
|---|---|---|---|
| Loading | Week 1-2 | Higher end of range (e.g., 500 mcg 2x/day) | Saturate tissue, initiate healing cascade |
| Maintenance | Week 3-6 | Standard range (e.g., 250-350 mcg 2x/day) | Sustain healing, consolidate progress |
| Off-cycle | 2-4 weeks | No BPC-157 | Receptor resensitization, assess baseline |
Cycle Length by Goal
| Goal | Recommended Cycle | Notes |
|---|---|---|
| Minor soft tissue injury | 4 weeks | Often sufficient for mild strains |
| Moderate injury (tendon, ligament) | 6 weeks | Standard protocol length |
| Chronic/severe injury | 8 weeks | Extended under practitioner guidance |
| Gut healing | 6-8 weeks | Oral or SubQ administration |
| General recovery support | 4 weeks | Lower doses adequate |
Off-Cycle Importance
Continuous BPC-157 use without breaks may lead to receptor desensitization, diminishing the peptide effectiveness over time. Leading practitioners recommend a minimum 2-week off-cycle between rounds. During off-cycle periods, track your recovery trajectory to determine whether additional cycles are warranted.
Reconstitution and Dose Calculation
Accurate reconstitution is the bridge between your target dose in micrograms and the actual volume you draw into a syringe. Errors here are the most common source of dosing mistakes.
Step-by-Step Reconstitution
- Gather materials: BPC-157 vial (typically 5 mg lyophilized), bacteriostatic water (BAC water), insulin syringe (typically 100-unit/1 mL)
- Choose reconstitution volume: Common choices are 1 mL or 2 mL of BAC water
- Add water to vial: Direct the stream along the glass wall, never directly onto the powder. Let it dissolve — do not shake
- Calculate concentration:
| Vial Size | BAC Water Added | Concentration | 250 mcg = | 500 mcg = |
|---|---|---|---|---|
| 5 mg | 1 mL | 5000 mcg/mL | 5 units (0.05 mL) | 10 units (0.10 mL) |
| 5 mg | 2 mL | 2500 mcg/mL | 10 units (0.10 mL) | 20 units (0.20 mL) |
| 10 mg | 2 mL | 5000 mcg/mL | 5 units (0.05 mL) | 10 units (0.10 mL) |
The DoseCraft Calculator performs this math instantly — enter vial size, water volume, and desired dose to see the exact syringe units with a visual representation.
Administration Routes
BPC-157 can be administered via multiple routes, each with distinct advantages.
Subcutaneous Injection (Most Common)
- Technique: Pinch skin, insert needle at 45-degree angle into subcutaneous fat, inject slowly, release pinch
- Best for: Targeted healing (inject near injury), general systemic use (inject in abdominal fat)
- Needle: 29-31 gauge, 1/2 inch insulin syringe
Intramuscular Injection
- Technique: Insert needle at 90-degree angle into target muscle
- Best for: Deep muscle injuries
- Needle: 27-29 gauge, 1 inch
Oral Administration — NOT RECOMMENDED
- Status: Ineffective. Gastric enzymes (pepsin, trypsin, chymotrypsin) destroy the 15-amino-acid peptide chain before systemic absorption.
- For gut healing: Use abdominal subcutaneous injection instead. BPC-157 promotes gut mucosal repair through systemic signaling — it does not need to physically contact the GI lining.
- Note: Companies selling oral BPC-157 capsules are selling expensive amino acids. All published BPC-157 studies used injectable routes.
Injection Site Selection and Rotation
Site Selection Strategy
| Goal | Recommended Injection Site |
|---|---|
| Knee/lower leg injury | Subcutaneous near the knee |
| Shoulder injury | Subcutaneous near the shoulder |
| Elbow tendon issue | Subcutaneous near the elbow |
| Gut healing | Abdominal subcutaneous (oral is ineffective) |
| General recovery | Abdominal subcutaneous (rotating quadrants) |
| Systemic effects | Any convenient subcutaneous site |
Rotation Protocol
Rotate injection sites to prevent lipodystrophy (tissue changes from repeated injections in the same spot). A simple 4-quadrant abdominal rotation works well:
- Upper-left abdomen
- Upper-right abdomen
- Lower-left abdomen
- Lower-right abdomen
Repeat the cycle, never injecting the same quadrant on consecutive administrations.
Protocol Design by Experience Level
Beginner Protocol
- Dose: 250 mcg subcutaneous, 2x daily
- Cycle: 4 weeks on, 2 weeks off
- Reconstitution: 5 mg vial + 2 mL BAC water (10 units per 250 mcg dose)
- Monitoring: Daily injection log, weekly progress notes
- Stacking: None (solo to assess individual response)
Intermediate Protocol
- Dose: 500 mcg subcutaneous, 2x daily (loading week 1-2), then 250 mcg 2x daily (maintenance)
- Cycle: 6 weeks on, 3 weeks off
- Reconstitution: 5 mg vial + 1 mL BAC water (10 units per 500 mcg, 5 units per 250 mcg)
- Monitoring: Daily log, weekly progress, bloodwork at week 3
- Stacking: Consider adding TB-500 for synergistic healing
Advanced Protocol
- Dose: 500 mcg subcutaneous near injury, 2x daily, full 6-week cycle with no step-down
- Cycle: 6-8 weeks on, 4 weeks off
- Stacking: BPC-157 + TB-500 (2.5 mg TB-500 2x/week loading, 2.5 mg 1x/week maintenance)
- Monitoring: Full injection log, weekly measurements, bloodwork at weeks 3 and 6
- Tool: Build this exact protocol in the DoseCraft Protocol Builder
Monitoring Your Protocol
Tracking results is essential for determining whether your dosage is optimized.
What to Track Daily
- Injection time, dose, and site
- Pain levels (1-10 scale)
- Range of motion (if applicable)
- Energy and sleep quality
- Any side effects (nausea, lightheadedness, injection site reactions)
What to Track Weekly
- Progress photos (if visible injury)
- Functional assessments (strength, flexibility, pain-free range)
- Overall recovery trajectory
Bloodwork Markers
| Marker | Why | Timing |
|---|---|---|
| CRP (C-reactive protein) | Inflammation baseline and response | Pre-cycle, week 3, post-cycle |
| Liver enzymes (AST, ALT) | Safety monitoring | Pre-cycle, post-cycle |
| CBC | General health baseline | Pre-cycle, post-cycle |
Use the DoseCraft app to log all of these data points alongside your injection history for a complete protocol record.
Common Dosage Mistakes
| Mistake | Why It Happens | How to Avoid |
|---|---|---|
| Inconsistent timing | Life gets busy | Set phone alarms or use DoseCraft reminders |
| Wrong syringe calculation | Mental math errors with reconstitution | Always use a calculator |
| Skipping off-cycle | Feeling good, do not want to stop | Schedule off-cycle in advance |
| Starting too high | Impatience | Begin at the conservative end; titrate up |
| Not tracking | Think you will remember | You will not. Log every injection |
| Same injection site | Convenience | Use rotation protocol |
Frequently Asked Questions
What is the best BPC-157 dosage for beginners?
Most clinical experts recommend starting at 250 mcg administered subcutaneously twice daily (500 mcg total daily). This falls within the well-documented effective range while minimizing the risk of side effects. After assessing your response over 1-2 weeks, you can adjust upward if needed. Use the DoseCraft Calculator to determine exact syringe units for your reconstitution setup.
How long does a BPC-157 cycle last?
Standard cycles range from 4-8 weeks depending on the severity of the issue being addressed. Minor soft tissue injuries often respond within 4 weeks, while more significant tendon, ligament, or chronic issues may require 6-8 weeks. Always follow a cycle with a 2-4 week off-period before considering another round.
Can I take BPC-157 orally instead of injecting?
No. Oral BPC-157 capsules are ineffective. Gastric enzymes (pepsin, trypsin, chymotrypsin) destroy the 15-amino-acid peptide chain before it can reach therapeutic concentrations in systemic circulation. Despite marketing claims about BPC-157's gastric origin and acid resistance, surviving stomach acid is not the same as surviving enzymatic degradation. All published studies demonstrating BPC-157's therapeutic effects used injectable routes. For gut healing, use abdominal subcutaneous injection.
Should I take BPC-157 on an empty stomach?
Most expert protocols recommend administering BPC-157 on an empty stomach or at least 30 minutes before eating. This may enhance absorption and growth factor signaling. However, the evidence for this timing preference is primarily practitioner-derived rather than from controlled trials.
How many vials of BPC-157 do I need for a full cycle?
For a standard 6-week cycle at 500 mcg/day (250 mcg 2x daily): 6 weeks x 7 days x 500 mcg = 21,000 mcg = 21 mg total. With 5 mg vials, you need approximately 4-5 vials. The DoseCraft Protocol Builder calculates vial requirements automatically based on your configured protocol.
What happens if I miss a BPC-157 dose?
Take it as soon as you remember, then resume your regular schedule. Do not double the next dose to compensate. Occasional missed doses are unlikely to significantly impact results, but consistent adherence is important for optimal outcomes. Track missed doses in your protocol log.
Can I combine BPC-157 with TB-500?
The BPC-157 + TB-500 stack is the most widely used peptide combination for healing. Their mechanisms are complementary — BPC-157 drives local angiogenesis while TB-500 promotes systemic cell migration via actin upregulation. Explore stacking protocols in the DoseCraft Library.
Build Your BPC-157 Dosage Protocol
Ready to design your protocol with precision? The DoseCraft Protocol Builder walks you through compound selection, dose configuration, cycle planning, and reminder setup. Check the BPC-157 compound profile for the full evidence-tiered reference, or start with the Calculator to nail your reconstitution math.
Not medical advice — educational only. This content has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before beginning any peptide protocol.